Annual Total Liabilities
$4.13 M
-$12.72 M-75.48%
December 31, 2023
Summary
- As of February 8, 2025, INTS annual total liabilities is $4.13 million, with the most recent change of -$12.72 million (-75.48%) on December 31, 2023.
- During the last 3 years, INTS annual total liabilities has fallen by -$7.58 million (-64.70%).
- INTS annual total liabilities is now -75.48% below its all-time high of $16.86 million, reached on December 31, 2022.
Performance
INTS Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$2.43 M
-$894.00 K-26.86%
September 30, 2024
Summary
- As of February 8, 2025, INTS quarterly total liabilities is $2.43 million, with the most recent change of -$894.00 thousand (-26.86%) on September 30, 2024.
- Over the past year, INTS quarterly total liabilities has stayed the same.
- INTS quarterly total liabilities is now -85.61% below its all-time high of $16.91 million, reached on March 31, 2023.
Performance
INTS Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
INTS Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -75.5% | 0.0% |
| 3 y3 years | -64.7% | -85.6% |
| 5 y5 years | -63.5% | -85.6% |
INTS Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -75.5% | at low | -85.6% | +169.0% |
| 5 y | 5-year | -75.5% | at low | -85.6% | +169.0% |
| alltime | all time | -75.5% | at low | -85.6% | +169.0% |
Intensity Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.43 M(-26.9%) |
| Jun 2024 | - | $3.33 M(+23.9%) |
| Mar 2024 | - | $2.69 M(-35.0%) |
| Dec 2023 | $4.13 M(-75.5%) | $4.13 M(+356.7%) |
| Sep 2023 | - | $904.90 K(-70.8%) |
| Jun 2023 | - | $3.09 M(-81.7%) |
| Mar 2023 | - | $16.91 M(+0.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $16.86 M(+21.3%) | $16.86 M(+14.2%) |
| Jun 2022 | - | $14.75 M(+1.7%) |
| Mar 2022 | - | $14.50 M(+4.3%) |
| Dec 2021 | $13.90 M(+18.7%) | - |
| Dec 2021 | - | $13.90 M(-5.1%) |
| Sep 2021 | - | $14.65 M(+25.1%) |
| Dec 2020 | $11.71 M(+3.5%) | $11.71 M |
| Dec 2019 | $11.31 M | - |
FAQ
- What is Intensity Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Intensity Therapeutics?
- What is Intensity Therapeutics annual total liabilities year-on-year change?
- What is Intensity Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Intensity Therapeutics?
- What is Intensity Therapeutics quarterly total liabilities year-on-year change?
What is Intensity Therapeutics annual total liabilities?
The current annual total liabilities of INTS is $4.13 M
What is the all time high annual total liabilities for Intensity Therapeutics?
Intensity Therapeutics all-time high annual total liabilities is $16.86 M
What is Intensity Therapeutics annual total liabilities year-on-year change?
Over the past year, INTS annual total liabilities has changed by -$12.72 M (-75.48%)
What is Intensity Therapeutics quarterly total liabilities?
The current quarterly total liabilities of INTS is $2.43 M
What is the all time high quarterly total liabilities for Intensity Therapeutics?
Intensity Therapeutics all-time high quarterly total liabilities is $16.91 M
What is Intensity Therapeutics quarterly total liabilities year-on-year change?
Over the past year, INTS quarterly total liabilities has changed by $0.00 (0.00%)